Biotin prices in Germany registered a consistent fall of almost 2% throughout August 2025. The bearish sentiment in the market was caused by subdued Biotin downstream demand, firm yet unimpressive supplies, and risk-hedging trading. Even with the firm supplies on offer, the weaker pull from end-use applications like pharma, animal nutrition, and dietary supplements supported overall downtrend.
Key Highlights
On the demand side, German Biotin market experienced minimal offtake by key industries. The pharmaceutical sector which utilizes Biotin in its products registered cautious buying in light of well-stocked inventories. The animal feed sector, a substantial user of Biotin in general, registered normal buying as feed manufacturers focused on cost-cutting. The dietary supplements business was also weak, with retailers continuing cautious buying in expectation of weaker prices. This overall slowing of demand meant that Biotin lacked the boost needed for stability.
From the demand side, Germany's excess reliance on Chinese imports kept domestic prices in close sympathy with the Chinese market. As Chinese manufacturers operated at levels and provided sufficient export availability, German purchasers were not confronted by any supply shortages. The size of surfeit supply against poor demand, however, remained in the air and pushed prices down. In the future, though, if Chinese manufacturers realign export volumes or downstream restocking accelerates, pressure from oversupply may relax with room for modest price rises.
Diving Deep into ChemAnalyst’s Quantitative Analysis
What annual trend of Biotin shows?
Historically, Biotin prices in Germany have followed seasonal demand cycles, often softening in late summer before rebounding later in the year. August 2025 showed a synchronized decline in both China and Germany, highlighting the structural linkage between the two markets and the influence of global trade flows. The stable demand base, however, suggests that unlike past sharp drops, the upcoming months may bring steadier pricing trends or even gradual increases as restocking and year-end procurement activity pick up.
What does the current market indicate?
The steady but modest downswings in August indicate a weak and not collapsing market. As trading volumes have been stable and seasonal restocking is forecasted in due course later in the year, the prices of Biotin can recover. Although China's Golden Week will not be in a position to generate an instant boost to demand, the medium-term picture is hopefully encouraging aided by strong supply fundamentals and anticipation of recovering downstream activity. Both German and Chinese prices are thus also expected to firm and most likely continue rising in the next few months.
